Updated Parkinson's Disease Motor Subtypes Classification and Correlation to Cerebrospinal Homovanillic Acid and 5-hydroxyindoleacetic Acid Levels
Overview
Authors
Affiliations
Introduction: Motor classifications of Parkinson's Disease (PD) have been widely used. This paper aims to update a subtype classification using the MDS-UPDRS-III and determine if cerebrospinal neurotransmitter profiles (HVA and 5-HIAA) differ between these subtypes in a cohort from the Parkinson's Progression Marker Initiative (PPMI).
Methods: UPDRS and MDS-UPDRS scores were collected for 20 PD patients. Akinetic-rigid (AR), Tremor-dominant (TD), and Mixed (MX) subtypes were calculated using a formula derived from UPDRS, and a new ratio was developed for subtyping patients with the MDS-UPDRS. This new formula was subsequently applied to 95 PD patients from the PPMI dataset, and subtyping was correlated to neurotransmitter levels. Data were analyzed using receiver operating characteristic models and ANOVA.
Results: Compared to previous UPDRS classifications, the new MDS-UPDRS TD/AR ratios produced significant areas under the curve (AUC) for each subtype. The optimal sensitivity and specificity cutoff scores were ≥0.82 for TD, ≤0.71 for AR, and >0.71 and <0.82 for Mixed. Analysis of variance showed that the AR group had significantly lower HVA and 5-HIAA levels than the TD and HC groups. A logistic model using neurotransmitter levels and MDS-UPDRS-III could predict the subtype classification.
Conclusions: This MDS-UPDRS motor classification system provides a method to transition from the original UPDRS to the new MDS-UPDRS. It is a reliable and quantifiable subtyping tool for monitoring disease progression. The TD subtype is associated with lower motor scores and higher HVA levels, while the AR subtype is associated with higher motor scores and lower 5-HIAA levels.
Fernandez-Perez J, Avendano-Coy J, Serrano-Munoz D, Barroso F, Montero-Pardo C, Lopez-Moreno B J Clin Med. 2025; 13(24.
PMID: 39768489 PMC: 11727874. DOI: 10.3390/jcm13247566.
Martin A, Nassif J, Chaluvadi L, Schammel C, Newman-Norlund R, Bollmann S Neuroimage Clin. 2024; 45:103724.
PMID: 39673940 PMC: 11699459. DOI: 10.1016/j.nicl.2024.103724.
Huyen Thi Dang T, Truong D, Vinh Nguyen K, Le Ngoc Ha U, Chung Ngoc Vo K, Nguyen T Clin Park Relat Disord. 2024; 11:100270.
PMID: 39318472 PMC: 11420436. DOI: 10.1016/j.prdoa.2024.100270.
The greatest loss of unpleasant smells may be related to the risk of more severe PD symptoms.
Chiu S, Fang T, Lei H, Lin Y, Chang M, Guo Y Front Neurol. 2024; 15:1362763.
PMID: 38628698 PMC: 11018954. DOI: 10.3389/fneur.2024.1362763.